$2.56 Billion is the total value of Tekla Capital Management LLC's 166 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 16.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Buy | Amgen Inc. | $136,883,989 | +1.8% | 616,539 | +10.9% | 5.36% | +4.7% |
| JNJ | Johnson & Johnson | $119,468,860 | +6.8% | 721,779 | 0.0% | 4.68% | +9.8% | |
| GILD | Sell | Gilead Sciences, Inc. | $118,216,440 | -8.7% | 1,533,884 | -1.7% | 4.63% | -6.1% |
| REGN | Buy | Regeneron Pharmaceuticals, Inc. | $115,985,290 | -1.3% | 161,418 | +12.8% | 4.54% | +1.4% |
| VRTX | Sell | Vertex Pharmaceuticals Inc. | $111,922,512 | +7.5% | 318,043 | -3.7% | 4.38% | +10.5% |
| LLY | Sell | Eli Lilly and Company | $100,057,821 | +0.8% | 213,352 | -26.2% | 3.92% | +3.7% |
| UNH | Sell | Unitedhealth Group Inc. | $99,473,735 | -10.1% | 206,961 | -11.6% | 3.89% | -7.6% |
| MRK | Buy | Merck & Co., Inc. | $84,021,690 | +43.0% | 728,154 | +31.9% | 3.29% | +47.0% |
| ABBV | Buy | AbbVie Inc. | $73,512,595 | -9.8% | 545,629 | +6.7% | 2.88% | -7.3% |
| BIIB | Buy | Biogen Inc. | $70,626,564 | +5.4% | 247,943 | +2.9% | 2.76% | +8.4% |
| AZN | Sell | AstraZeneca PLCsponsored adr | $69,900,701 | +1.5% | 976,676 | -1.6% | 2.74% | +4.3% |
| ILMN | Sell | Illumina, Inc. | $63,180,193 | -21.9% | 336,979 | -3.2% | 2.47% | -19.8% |
| ABT | Sell | Abbott Laboratories | $60,228,644 | -4.7% | 552,455 | -11.4% | 2.36% | -2.0% |
| PFE | Sell | Pfizer Inc. | $59,585,780 | -17.7% | 1,624,476 | -8.5% | 2.33% | -15.4% |
| TMO | Buy | Thermo Fisher Scientific Inc. | $51,646,467 | -4.4% | 98,987 | +5.6% | 2.02% | -1.7% |
| ANTM | Elevance Health, Inc. | $50,680,160 | -3.4% | 114,070 | 0.0% | 1.98% | -0.7% | |
| MRNA | Buy | Moderna, Inc. | $41,758,943 | -15.6% | 343,695 | +6.7% | 1.63% | -13.3% |
| BSX | Buy | Boston Scientific Corp. | $35,579,861 | +25.7% | 657,790 | +16.2% | 1.39% | +29.1% |
| DHR | Buy | Danaher Corp. | $34,275,120 | +28.7% | 142,813 | +35.1% | 1.34% | +32.2% |
| MDT | Sell | Medtronic plcshares | $30,343,138 | +9.2% | 344,417 | -0.0% | 1.19% | +12.3% |
| IDXX | IDEXX Laboratories, Inc. | $29,428,167 | +0.4% | 58,595 | 0.0% | 1.15% | +3.2% | |
| DXCM | Dexcom, Inc. | $29,396,277 | +10.6% | 228,747 | 0.0% | 1.15% | +13.6% | |
| BMY | Sell | Bristol-Myers Squibb Company | $29,320,947 | -36.3% | 458,498 | -30.9% | 1.15% | -34.5% |
| ISRG | Sell | Intuitive Surgical, Inc. | $28,716,121 | -0.2% | 83,980 | -25.5% | 1.12% | +2.6% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $27,202,067 | -5.2% | 143,214 | 0.0% | 1.06% | -2.5% | |
| CI | Sell | The Cigna Group | $27,032,723 | -42.1% | 96,339 | -47.2% | 1.06% | -40.5% |
| MCK | Sell | McKesson Corp. | $26,473,991 | +11.9% | 61,955 | -6.8% | 1.04% | +15.0% |
| ARGX | Sell | argenx SEsponsored adr | $25,547,971 | -22.4% | 65,553 | -25.8% | 1.00% | -20.2% |
| HCA | Sell | HCA Healthcare, Inc. | $25,007,662 | +6.9% | 82,403 | -7.1% | 0.98% | +10.0% |
| SYK | Buy | Stryker Corp. | $24,751,342 | +21.1% | 81,128 | +13.3% | 0.97% | +24.6% |
| IQV | Buy | IQVIA Holdings Inc. | $24,528,925 | +95.4% | 109,129 | +72.9% | 0.96% | +100.8% |
| ZTS | Zoetis Inc.class a | $23,577,960 | +3.5% | 136,914 | 0.0% | 0.92% | +6.3% | |
| CRL | Sell | Charles River Laboratories International, Inc. | $23,376,226 | -1.9% | 111,183 | -5.8% | 0.92% | +0.9% |
| SGEN | Sell | Seagen Inc. | $21,619,224 | -52.5% | 112,331 | -50.0% | 0.85% | -51.2% |
| SRPT | Sell | Sarepta Therapeutics, Inc. | $20,549,125 | -47.8% | 179,437 | -37.2% | 0.80% | -46.4% |
| NVO | Buy | Novo Nordisk A/Ssponsored adr | $19,869,002 | +12.2% | 122,777 | +10.3% | 0.78% | +15.4% |
| Oculis Holding AG | $18,823,020 | +70.4% | 1,690,741 | 0.0% | 0.74% | +75.1% | ||
| MOH | Molina Healthcare, Inc. | $18,633,501 | +12.6% | 61,856 | 0.0% | 0.73% | +15.7% | |
| JAZZ | Jazz Pharmaceuticals plcshares | $18,320,163 | -15.3% | 147,779 | 0.0% | 0.72% | -12.9% | |
| BMRN | Sell | BioMarin Pharmaceutical Inc. | $18,271,191 | -37.4% | 210,789 | -29.8% | 0.72% | -35.6% |
| EW | Buy | Edwards Lifesciences Corp. | $17,884,685 | +26.3% | 189,597 | +10.8% | 0.70% | +29.9% |
| HUM | Humana Inc. | $16,451,701 | -7.9% | 36,794 | 0.0% | 0.64% | -5.3% | |
| APLS | Buy | Apellis Pharmaceuticals, Inc. | $15,782,893 | +77.1% | 173,248 | +28.2% | 0.62% | +82.3% |
| BAX | Buy | Baxter International, Inc. | $14,778,297 | +441.3% | 324,370 | +381.9% | 0.58% | +455.8% |
| EXEL | Exelixis, Inc. | $13,886,071 | -1.5% | 726,639 | 0.0% | 0.54% | +1.1% | |
| NVS | Novartis AGsponsored adr | $13,746,465 | +9.7% | 136,225 | 0.0% | 0.54% | +12.8% | |
| KRTX | Buy | Karuna Therapeutics, Inc. | $12,702,422 | +30.8% | 58,577 | +9.6% | 0.50% | +34.3% |
| PODD | New | Insulet Corp. | $12,642,844 | – | 43,847 | +100.0% | 0.50% | – |
| GH | Sell | Guardant Health, Inc. | $12,389,807 | +11.9% | 346,084 | -26.7% | 0.48% | +15.2% |
| ASND | Buy | Ascendis Pharma A/Ssponsored adr | $12,387,097 | -6.7% | 138,791 | +12.1% | 0.48% | -4.0% |
| XBI | SPDR S&P Biotech ETFs&p biotech etf | $12,286,726 | +9.2% | 147,677 | 0.0% | 0.48% | +12.4% | |
| DOC | Physicians Realty Trust | $12,222,433 | -6.3% | 873,655 | 0.0% | 0.48% | -3.8% | |
| THC | New | Tenet Healthcare Corp. | $12,131,317 | – | 149,070 | +100.0% | 0.48% | – |
| BNTX | BioNTech SEsponsored ads | $11,209,394 | -13.4% | 103,858 | 0.0% | 0.44% | -11.0% | |
| NBIX | Neurocrine Biosciences, Inc. | $10,647,224 | -6.8% | 112,908 | 0.0% | 0.42% | -4.1% | |
| ZBH | Zimmer Biomet Holdings, Inc. | $9,807,034 | +12.7% | 67,356 | 0.0% | 0.38% | +16.0% | |
| Rallybio Corporation | $9,775,199 | -0.9% | 1,727,067 | 0.0% | 0.38% | +2.1% | ||
| PCVX | Buy | Vaxcyte, Inc. | $9,699,946 | +5076.1% | 194,232 | +3784.6% | 0.38% | +5328.6% |
| ALKS | Alkermes plcshares | $9,690,887 | +11.0% | 309,613 | 0.0% | 0.38% | +14.2% | |
| DNLI | Denali Therapeutics, Inc. | $9,585,704 | +28.1% | 324,829 | 0.0% | 0.38% | +31.6% | |
| AVTR | Avantor, Inc. | $9,437,884 | -2.8% | 459,488 | 0.0% | 0.37% | -0.3% | |
| OHI | Omega Healthcare Investors, Inc. | $9,404,429 | +12.0% | 306,433 | 0.0% | 0.37% | +15.0% | |
| UTHR | Sell | United Therapeutics Corp. | $9,153,399 | -33.2% | 41,465 | -32.2% | 0.36% | -31.4% |
| ITCI | Sell | Intra-Cellular Therapies, Inc. | $8,322,464 | -10.8% | 131,435 | -23.7% | 0.33% | -8.2% |
| ACHC | Sell | Acadia Healthcare Company, Inc. | $8,036,632 | -40.4% | 100,912 | -45.9% | 0.31% | -38.8% |
| MDGL | Buy | Madrigal Pharmaceuticals, Inc. | $7,954,254 | +163.1% | 34,434 | +175.9% | 0.31% | +170.4% |
| RMD | Sell | ResMed Inc. | $7,582,824 | -52.7% | 34,704 | -52.6% | 0.30% | -51.3% |
| HZNP | New | Horizon Therapeutics plc | $7,448,911 | – | 72,425 | +100.0% | 0.29% | – |
| INSP | New | Inspire Medical Systems, Inc. | $7,147,924 | – | 22,018 | +100.0% | 0.28% | – |
| CYTK | Cytokinetics, Inc. | $7,144,596 | -7.3% | 219,025 | 0.0% | 0.28% | -4.4% | |
| STE | STERIS plcshares | $6,990,579 | +17.6% | 31,072 | 0.0% | 0.27% | +21.2% | |
| SNY | Sanofisponsored adr | $6,654,171 | -1.0% | 123,454 | 0.0% | 0.26% | +1.6% | |
| R1 RCM Inc. | $6,583,901 | +23.0% | 356,851 | 0.0% | 0.26% | +26.5% | ||
| CVS | CVS Health Corp. | $6,472,020 | -7.0% | 93,621 | 0.0% | 0.25% | -4.5% | |
| MEDP | Buy | Medpace Holdings, Inc. | $6,464,896 | +264.4% | 26,918 | +185.3% | 0.25% | +272.1% |
| IMVT | Buy | Immunovant, Inc. | $6,377,714 | +256.3% | 336,200 | +191.3% | 0.25% | +267.6% |
| NTLA | Intellia Therapeutics, Inc. | $6,291,090 | +9.4% | 154,269 | 0.0% | 0.25% | +12.3% | |
| LTC | LTC Properties, Inc. | $6,019,315 | -6.0% | 182,293 | 0.0% | 0.24% | -3.3% | |
| SBRA | Sabra Health Care REIT, Inc. | $6,010,468 | +2.3% | 510,660 | 0.0% | 0.24% | +4.9% | |
| SNN | Smith & Nephew plcsponsored adr | $5,860,148 | +15.5% | 181,710 | 0.0% | 0.23% | +18.7% | |
| KDNY | Buy | Chinook Therapeutics, Inc. | $5,796,156 | +199.8% | 150,863 | +80.7% | 0.23% | +206.8% |
| WST | West Pharmaceutical Services, Inc. | $5,750,819 | +10.4% | 15,036 | 0.0% | 0.22% | +13.6% | |
| CERE | Cerevel Therapeutics Holdings, Inc. | $5,610,395 | +30.3% | 176,483 | 0.0% | 0.22% | +34.1% | |
| LIVN | Buy | LivaNova plc | $5,579,126 | +100.4% | 108,480 | +69.8% | 0.22% | +105.7% |
| MDRX | Veradigm, Inc. | $5,400,108 | -3.4% | 428,580 | 0.0% | 0.21% | -0.9% | |
| A | Agilent Technologies, Inc. | $5,193,718 | -13.1% | 43,191 | 0.0% | 0.20% | -10.6% | |
| Sell | Marinus Pharmaceuticals, Inc. | $4,464,557 | +41.7% | 411,101 | -10.0% | 0.18% | +45.8% | |
| QURE | Sell | uniQure N.V.shares | $4,082,969 | -68.9% | 356,280 | -45.4% | 0.16% | -68.0% |
| ABC | Amerisourcebergen Corp. | $3,928,843 | +20.2% | 20,417 | 0.0% | 0.15% | +24.2% | |
| MPW | Medical Properties Trust, Inc. | $3,812,740 | +12.7% | 411,743 | 0.0% | 0.15% | +15.5% | |
| BGNE | BeiGene, Ltd.sponsored adr | $3,735,742 | -17.3% | 20,952 | 0.0% | 0.15% | -15.1% | |
| IONS | Ionis Pharmaceuticals, Inc. | $3,604,075 | +14.8% | 87,840 | 0.0% | 0.14% | +17.5% | |
| BCRX | BioCryst Pharmaceuticals, Inc. | $3,551,877 | -15.6% | 504,528 | 0.0% | 0.14% | -13.1% | |
| RETA | Buy | Reata Pharmaceuticals, Inc. Class Aclass a | $3,492,130 | +115.2% | 34,250 | +91.9% | 0.14% | +121.0% |
| TEVA | Teva Pharmaceutical Industries Ltd.sponsored adr | $3,461,172 | -14.9% | 459,651 | 0.0% | 0.14% | -12.9% | |
| WELL | Welltower Inc. | $3,355,641 | +12.8% | 41,484 | 0.0% | 0.13% | +15.9% | |
| Healthcare Realty Trust Inc. | $3,294,578 | -2.4% | 174,686 | 0.0% | 0.13% | 0.0% | ||
| VTR | Ventas, Inc. | $3,152,011 | +9.0% | 66,681 | 0.0% | 0.12% | +11.8% | |
| IBB | Ishares Biothechnology ETF | $3,119,280 | -1.7% | 24,569 | 0.0% | 0.12% | +0.8% | |
| PEAK | Healthpeak Properties, Inc. | $3,022,879 | -8.5% | 150,392 | 0.0% | 0.12% | -6.3% | |
| AKRO | New | Akero Therapeutics, Inc. | $2,871,295 | – | 61,497 | +100.0% | 0.11% | – |
| ADPT | Adaptive Biotechnologies Corp. | $2,833,506 | -24.0% | 422,281 | 0.0% | 0.11% | -21.8% | |
| GRTX | Galera Therapeutics, Inc. | $2,802,927 | +21.9% | 898,374 | 0.0% | 0.11% | +25.0% | |
| BBIO | Bridgebio Pharma, Inc. | $2,595,841 | +3.7% | 150,921 | 0.0% | 0.10% | +7.4% | |
| XENE | Sell | Xenon Pharmaceuticals Inc. | $2,598,981 | -13.3% | 67,506 | -19.4% | 0.10% | -10.5% |
| PHG | Buy | Koninklijke Philips N.V.ny reg shares | $2,489,253 | +23.5% | 114,765 | +4.5% | 0.10% | +26.0% |
| Caribou Biosciences, Inc. | $2,410,375 | -20.0% | 567,147 | 0.0% | 0.09% | -18.3% | ||
| MRTX | Mirati Therapeutics, Inc. | $2,366,154 | -2.8% | 65,490 | 0.0% | 0.09% | 0.0% | |
| ICLR | Icon plcshares | $2,335,367 | +17.1% | 9,334 | 0.0% | 0.09% | +19.7% | |
| New | Amylyx Pharmaceuticals, Inc. | $2,243,431 | – | 104,007 | +100.0% | 0.09% | – | |
| ASRT | Assertio Holdings, Inc. | $2,225,317 | -14.9% | 410,575 | 0.0% | 0.09% | -13.0% | |
| MREO | Mereo BioPharma Group plcads | $2,047,428 | +86.7% | 1,551,082 | 0.0% | 0.08% | +90.5% | |
| ETNB | 89bio, Inc. | $2,006,767 | +24.4% | 105,898 | 0.0% | 0.08% | +29.5% | |
| ARDX | Ardelyx, Inc. | $1,828,593 | -29.2% | 539,408 | 0.0% | 0.07% | -26.5% | |
| Pyxis Oncology, Inc. | $1,813,256 | -36.2% | 708,303 | 0.0% | 0.07% | -34.3% | ||
| PRGO | Perrigo Company plcshares | $1,739,055 | -5.4% | 51,224 | 0.0% | 0.07% | -2.9% | |
| TAK | Takeda Pharmaceutical Company Ltd.sponsored ads | $1,650,697 | -4.7% | 105,073 | 0.0% | 0.06% | -1.5% | |
| GMRE | Global Medical REIT Inc. | $1,596,810 | +0.2% | 174,897 | 0.0% | 0.06% | +1.6% | |
| GSK plcsponsored adr | $1,491,605 | +0.2% | 41,852 | 0.0% | 0.06% | +1.8% | ||
| TCMD | Buy | Tactile Systems Technology, Inc. | $1,457,707 | +157.8% | 58,472 | +69.8% | 0.06% | +159.1% |
| ARQT | Arcutis Biotherapeutics, Inc. | $1,418,769 | -13.4% | 148,874 | 0.0% | 0.06% | -9.7% | |
| XNCR | New | Xencor, Inc. | $1,415,175 | – | 56,675 | +100.0% | 0.06% | – |
| CRNX | Crinetics Pharmaceuticals, Inc. | $1,415,093 | +12.2% | 78,529 | 0.0% | 0.06% | +14.6% | |
| MOR | Buy | MorphoSys AGsponsored ads | $1,323,617 | +309.3% | 177,191 | +116.4% | 0.05% | +333.3% |
| CRSP | Sell | CRISPR Therapeutics AGnamen akt | $1,267,136 | -49.1% | 22,571 | -59.0% | 0.05% | -47.4% |
| NTRA | Sell | Natera, Inc. | $1,198,788 | -56.2% | 24,636 | -50.0% | 0.05% | -54.8% |
| EWTX | Sell | Edgewise Therapeutics, Inc. | $1,165,740 | -10.4% | 150,418 | -22.9% | 0.05% | -8.0% |
| ZNTL | New | Zentalis Pharmaceuticals, Inc. | $1,132,801 | – | 40,156 | +100.0% | 0.04% | – |
| BCYC | Sell | Bicycle Therapeutics PLCsponsored ads | $1,131,506 | -40.0% | 44,338 | -50.0% | 0.04% | -38.9% |
| GTHX | G1 Therapeutics, Inc. | $1,055,434 | -7.1% | 423,869 | 0.0% | 0.04% | -4.7% | |
| FULC | Buy | Fulcrum Therapeutics, Inc. | $847,730 | +408.1% | 256,888 | +338.8% | 0.03% | +450.0% |
| SRRK | Scholar Rock Holding Corp. | $820,601 | -5.7% | 108,833 | 0.0% | 0.03% | -3.0% | |
| DHC | Diversified Healthcare Trust | $804,870 | +66.7% | 357,720 | 0.0% | 0.03% | +72.2% | |
| Theseus Pharmaceuticals, Inc. | $699,750 | +5.1% | 75,000 | 0.0% | 0.03% | +8.0% | ||
| RCUS | Arcus Biosciences, Inc. | $666,960 | +11.3% | 32,839 | 0.0% | 0.03% | +13.0% | |
| BDTX | Black Diamond Therapeutics, Inc. | $666,550 | +167.2% | 131,990 | 0.0% | 0.03% | +188.9% | |
| ITOS | iTeos Therapeutics, Inc. | $605,531 | -2.7% | 45,735 | 0.0% | 0.02% | 0.0% | |
| ICPT | Intercept Pharmaceuticals, Inc. | $575,861 | -17.6% | 52,067 | 0.0% | 0.02% | -14.8% | |
| NHI | National Health Investors, Inc. | $526,192 | +1.6% | 10,038 | 0.0% | 0.02% | +5.0% | |
| UHT | Universal Health Realty Income Trust | $535,656 | -1.1% | 11,258 | 0.0% | 0.02% | 0.0% | |
| BEAM | Beam Therapeutics Inc. | $505,037 | +4.3% | 15,817 | 0.0% | 0.02% | +11.1% | |
| TScan Therapeutics, Inc. | $500,000 | +19.0% | 200,000 | 0.0% | 0.02% | +25.0% | ||
| ALXO | ALX Oncology Holdings Inc. | $497,245 | +66.2% | 66,211 | 0.0% | 0.02% | +72.7% | |
| IMAB | I-Mabsponsored ads | $486,114 | -13.6% | 162,580 | 0.0% | 0.02% | -9.5% | |
| NVAX | Novavax, Inc. | $474,034 | +7.2% | 63,800 | 0.0% | 0.02% | +11.8% | |
| CHCT | Community Healthcare Trust Inc. | $491,998 | -9.8% | 14,900 | 0.0% | 0.02% | -9.5% | |
| STRO | Sutro Biopharma, Inc. | $457,346 | +0.6% | 98,354 | 0.0% | 0.02% | +5.9% | |
| New | HilleVax, Inc. | $464,130 | – | 27,000 | +100.0% | 0.02% | – | |
| CYH | Community Health Systems, Inc. | $388,674 | -10.2% | 88,335 | 0.0% | 0.02% | -6.2% | |
| AFMD | Affimed N.V. | $350,568 | -19.8% | 586,038 | 0.0% | 0.01% | -17.6% | |
| RPTX | Repare Therapeutics Inc. | $308,407 | +7.5% | 29,150 | 0.0% | 0.01% | +9.1% | |
| ALT | Altimmune, Inc. | $264,750 | -16.4% | 75,000 | 0.0% | 0.01% | -16.7% | |
| CDXS | Codexis Inc | $193,550 | -32.4% | 69,125 | 0.0% | 0.01% | -27.3% | |
| FUSN | Fusion Pharmaceuticals Inc. | $203,084 | +24.1% | 43,394 | 0.0% | 0.01% | +33.3% | |
| HARP | Harpoon Therapeutics, Inc. | $184,536 | -4.6% | 259,910 | 0.0% | 0.01% | 0.0% | |
| DTIL | Precision BioSciences, Inc. | $118,105 | -30.2% | 224,534 | 0.0% | 0.01% | -16.7% | |
| SPPI | Spectrum Pharmaceuticals, Inc. | $110,083 | +28.0% | 114,670 | 0.0% | 0.00% | +33.3% | |
| ACET | Adicet Bio, Inc. | $97,999 | -57.8% | 40,329 | 0.0% | 0.00% | -55.6% | |
| ABIO | ARCA biopharma, Inc. | $65,896 | +2.0% | 32,461 | 0.0% | 0.00% | +50.0% | |
| PRAX | Praxis Precision Medicines, Inc. | $86,250 | +42.2% | 75,000 | 0.0% | 0.00% | +50.0% | |
| Corbus Pharmaceuticals Holdings, Inc. | $40,321 | +7.8% | 5,143 | 0.0% | 0.00% | +100.0% | ||
| Mallinckrodt plcshares | $41,357 | -83.8% | 35,048 | 0.0% | 0.00% | -80.0% | ||
| NKTX | Nkarta, Inc. | $63,484 | -38.3% | 28,988 | 0.0% | 0.00% | -50.0% | |
| VYNE Therapeutics, Inc. | $30,531 | +31.8% | 7,520 | 0.0% | 0.00% | 0.0% | ||
| Bellicum Pharmaceuticals, Inc. | $2,220 | +12.1% | 6,000 | 0.0% | 0.00% | – | ||
| NexGel, Inc. | $10,650 | +93.1% | 4,243 | 0.0% | 0.00% | – | ||
| Exit | Biohaven Ltd. | $0 | – | -35,087 | -100.0% | -0.02% | – | |
| MRSN | Exit | Mersana Therapeutics, Inc. | $0 | – | -162,383 | -100.0% | -0.02% | – |
| ZLAB | Exit | Zai Lab Ltd.adr | $0 | – | -34,640 | -100.0% | -0.04% | – |
| MRUS | Exit | Merus N.V. | $0 | – | -69,025 | -100.0% | -0.05% | – |
| OPCH | Exit | Option Care Health, Inc. | $0 | – | -64,975 | -100.0% | -0.08% | – |
| ALGN | Exit | Align Technology, Inc. | $0 | – | -6,925 | -100.0% | -0.09% | – |
| SNDX | Exit | Syndax Pharmaceuticals, Inc. | $0 | – | -117,717 | -100.0% | -0.10% | – |
| ARWR | Exit | Arrowhead Pharmaceuticals, Inc. | $0 | – | -100,422 | -100.0% | -0.10% | – |
| RARE | Exit | Ultragenyx Pharmaceutical Inc. | $0 | – | -67,065 | -100.0% | -0.10% | – |
| BPMC | Exit | Blueprint Medicines Corp. | $0 | – | -67,710 | -100.0% | -0.12% | – |
| CTLT | Exit | Catalent, Inc. | $0 | – | -49,406 | -100.0% | -0.12% | – |
| CSII | Exit | Cardiovascular Systems, Inc. | $0 | – | -174,859 | -100.0% | -0.13% | – |
| KURA | Exit | Kura Oncology, Inc. | $0 | – | -283,281 | -100.0% | -0.13% | – |
| ADUS | Exit | Addus HomeCare Corp. | $0 | – | -42,380 | -100.0% | -0.17% | – |
| AMED | Exit | Amedisys, Inc. | $0 | – | -68,949 | -100.0% | -0.19% | – |
| RXDX | Exit | Prometheus Biosciences, Inc. | $0 | – | -50,538 | -100.0% | -0.21% | – |
| VECT | Exit | VectivBio Holding AG | $0 | – | -682,834 | -100.0% | -0.22% | – |
| LNTH | Exit | Lantheus Holdings, Inc. | $0 | – | -79,495 | -100.0% | -0.25% | – |
| LH | Exit | Laboratory Corporation of America Holdings | $0 | – | -40,042 | -100.0% | -0.35% | – |
| TVTX | Exit | Travere Therapeutics, Inc. | $0 | – | -418,520 | -100.0% | -0.36% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-08-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.